Koers Health Discovery Corporation Other OTC
Aandelen
HDVY
US42218R1005
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 1,52 mln. 1,4 mln. | Omzet 2020 | 1K 921,06 | Marktkapitalisatie | 18,27 mln. 16,83 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | 1 mln. 921K | Nettowinst (verlies) 2020 | - 0 | EV/omzet 2019 | 6,91 x |
Nettoliquiditeiten 2019 | 2,1 mln. 1,93 mln. | Nettoliquiditeiten 2020 | 705K 649K | EV/omzet 2020 | 17.568 x |
K/w-verhouding 2019 |
12,5
x | K/w-verhouding 2020 |
-22,6
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hong Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Morrison
BRD | Director/Board Member | 51 | 26-04-17 |
Director/Board Member | 49 | 09-05-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-31,06% | 9,3 mld. | |
-8,43% | 3,1 mld. | |
+27,31% | 2,87 mld. | |
-14,31% | 2,17 mld. | |
-18,94% | 1,75 mld. | |
+73,13% | 1,5 mld. | |
+30,25% | 807 mln. | |
-1,97% | 759 mln. | |
-26,73% | 532 mln. |